Primary Site >> Biliary tract Cancer

Overview

Mutation

Expression

Methylation

Prognosis

Literature

Timeline

Gene >> CYP2A6

2011	2012
Ref: Phase II study of S-1 combined with oxaliplatin as therapy for patients with metastatic biliary tract cancer: influence of the CYP2A6 polymorphism on pharmacokinetics and clinical activity. PMID: 21326246	Ref: Hepatic cytochrome P450 2A6 and 2E1 status in peri-tumor tissues of patients with Opisthorchis viverrini-associated cholangiocarcinoma. PMID: 21745589